Genetically predicted rheumatoid arthritis is causally associated with prostate cancer, according to study findings.
Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an observational study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback